Trademark: 90545048
Status Date
Monday, March 4, 2024
Filing Date
Wednesday, February 24, 2021
Published for Opposition
Tuesday, March 1, 2022
1 Biochemical catalysts; Biochemical preparations for scientific purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations used in science; Nucleic acid for laboratory use; Protein in raw material form for scientific and medical research; Reagents for research purposes; Reagents for scientific and research use; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; Antioxidants for use in the manufacture of pharmaceuticals; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Biometallic compounds for use in the manufacture of pharmaceutical preparations; Catalysts for chemical and biochemical processes; Cells for scientific, laboratory or medical research; Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in the biochemical and chemical industry; Chemicals for use in the purification of proteins for in vitro use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Enzymes for use in protein hydrolysis; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Plant extracts for use in the manufacture of pharmaceuticals; Protein arrays and nucleotide arrays for scientific and medical research; Reagents for scientific or medical research use
Mar 5, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 4, 2024
Sou Extension 4 Granted
Mar 4, 2024
Sou Extension 4 Filed
Mar 4, 2024
Sou Teas Extension Received
Oct 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 19, 2023
Sou Extension 3 Granted
Oct 19, 2023
Sou Extension 3 Filed
Oct 19, 2023
Sou Teas Extension Received
Mar 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 9, 2023
Sou Extension 2 Granted
Mar 9, 2023
Sou Extension 2 Filed
Mar 9, 2023
Sou Teas Extension Received
Oct 21, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 19, 2022
Sou Extension 1 Granted
Oct 19, 2022
Sou Extension 1 Filed
Oct 19, 2022
Sou Teas Extension Received
Oct 13, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 13, 2022
Teas Change Of Correspondence Received
Oct 13, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 13, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 13, 2022
Teas Change Of Owner Address Received
Apr 26, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 1, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 1, 2022
Published For Opposition
Feb 9, 2022
Notification Of Notice Of Publication E-Mailed
Jan 26, 2022
Approved For Pub - Principal Register
Jan 26, 2022
Examiner's Amendment Entered
Jan 26, 2022
Notification Of Examiners Amendment E-Mailed
Jan 26, 2022
Examiners Amendment E-Mailed
Jan 26, 2022
Examiners Amendment -Written
Dec 27, 2021
Teas/Email Correspondence Entered
Dec 26, 2021
Correspondence Received In Law Office
Dec 26, 2021
Teas Response To Office Action Received
Sep 15, 2021
Notification Of Non-Final Action E-Mailed
Sep 15, 2021
Non-Final Action E-Mailed
Sep 15, 2021
Non-Final Action Written
Sep 15, 2021
Assigned To Examiner
May 26, 2021
New Application Office Supplied Data Entered
Feb 27, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
